We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
83 hedge funds and large institutions have $75.2M invested in Sorrento Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
37% more call options, than puts
Call options by funds: $1.57M | Put options by funds: $1.15M
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
1% less funds holding
Funds holding: 84 → 83 (-1)
31% less capital invested
Capital invested by funds: $108M → $75.2M (-$33.2M)
Holders
83
Holders Change
-1
Holders Change %
-1.19%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
34
Reduced
17
Closed
9
Calls
$1.57M
Puts
$1.15M
Net Calls
+$422K
Net Calls Change
-$44K
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$7.53M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$5.04M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.38M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.61M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.43M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$352K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$333K |
| 3 |
Morgan Stanley
New York
|
-$330K |
| 4 |
D.E. Shaw & Co
New York
|
-$324K |
| 5 |
Axa
Paris,
France
|
-$210K |
